US Stocks
US Options
Emerging Asia
GBP Cash Savings
Charts & Tools
Paper Trading
Extended Hours
Wall Street Journal
TradingViewR
REGN
Regeneron Pharmaceuticals
746.80
20.59+2.84%After Hours: 746.80 0.00 0.00%16:10 12/11 EST
OPEN/PREV CLOSE726.98/726.21
TODAY RANGE726.46-753.57
VOL1.15M
MARKET CAP78.49B
52 WEEK RANGE475.17-796.57
AVG VOL (3M)1.10M
% TURNOVER1.09%
TURNOVER--
P/E (TTM)17.87
% RANGE3.73%
EPS(TTM)41.78
P/E(FORWARD)17.79
P/B2.540
BVPS294.00
DIVIDEND3.520
P/S5.76
BETA--
DIV YIELD0.47%
FREE FLOAT MKT CAP75.48B
SHARES OUTSTANDING105.10M
NEXT EARNINGS02/02-02/06
FREE FLOAT101.08M
LOT SIZE1
EX-DATE11/20/2025
News
Press Releases
Financial Reports
Profile
Seeking Alpha·1h ago
Biohaven jumps on early-stage data for antibody drug conjugate combo
TipRanks·6h ago
Regeneron (REGN) Receives a Buy from BMO Capital
TipRanks·8h ago
Regeneron (REGN) Gets a Hold from Scotiabank
Seeking Alpha·10h ago
Stock index futures slide as Oracle sinks post-earnings
Simply Wall St·16h ago
How Investors May Respond To Regeneron (REGN) Lynozyfic Multiple Myeloma Data And Frontline Oncology Ambitions
TipRanks·16h ago
Wells Fargo Keeps Their Hold Rating on Regeneron (REGN)
Dow Jones·23h ago
Regeneron Pharmaceuticals Inc. Stock Rises 4.9%, Outperforms Peers
Dow Jones·1d ago
Regeneron Pharma Is Maintained at Equal-Weight by Wells Fargo
TipRanks·1d ago
Regeneron price target raised to $985 from $890 at HSBC
Same Industry
Name/Symbol
Change%
Price